News
Achieve (ACHV) Q2 Net Loss Hits $12.7M
Achieve Life Sciences (NASDAQ:ACHV), a late-stage biopharmaceutical firm focused on therapies for nicotine dependence, released its second-quarter fiscal 2025 results on August 7, 2025. The headline
Cheniere (CQP) Q2 Revenue Jumps 30%
Cheniere Energy Partners (NYSE:CQP), a major liquefied natural gas exporter and operator of the Sabine Pass LNG Terminal, released its second quarter 2025 results on August 7, 2025. The most
Intellia (NTLA) Q2 Revenue Jumps 106%
Intellia Therapeutics (NASDAQ:NTLA), a biotechnology company developing CRISPR-based gene-editing therapies, reported second quarter 2025 results on August 7, 2025. The headline news was a
UMH UMH Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, Aug. 7, 2025 at 2:00 p.m. ET
President and Chief Executive Officer — Samuel Landy
Source Fool.com
Sabre (SABR) Q2 Revenue Falls 1%
Sabre (NASDAQ:SABR), a global technology provider for the travel industry, released its earnings for the second quarter on August 7, 2025. The standout story for this period was mixed operational
Cars.com (CARS) Q2 EPS Misses by 2%
Cars.com (NYSE:CARS), the well-known digital automotive marketplace and technology company, released its second quarter fiscal 2025 results on August 7, 2025. According to the release, The company
Texas Pacific Land Earnings Call Transcript
Image source: The Motley Fool.
Thursday, August 7, 2025 at 2:30 p.m. ET
Chief Executive Officer — Tyler Glover
Source Fool.com
Enterprise (EPD) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Monday, July 28, 2025, at 10 a.m. ET
Need a quote from one of our analysts? Email [email protected]
Source Fool.com
Chicago Atlantic (REFI) Q2 EPS Beats 9%
Chicago Atlantic Real Estate Finance (NASDAQ:REFI), a specialty finance company focused on lending to the regulated cannabis industry, announced its second quarter 2025 results on August 7, 2025
Crocs (CROX) Q2 EPS Beats by 5%
Crocs (NASDAQ:CROX), the casual footwear company known for its distinctive clogs and focus on comfort, reported financial results for Q2 2025 on August 7, 2025. The headline news was a beat on both
SPB Sales Drop 10%
Spectrum Brands (NYSE:SPB), the global consumer products company known for brands across pet care, home and garden, and appliances, reported its earnings for the third quarter of fiscal 2025 on
DTIL Revenue Drops 99%
Precision BioSciences (NASDAQ:DTIL), a clinical-stage biotechnology firm focused on gene editing, released its Q2 FY2025 earnings results on August 7, 2025. The main headline: GAAP revenue dropped
Amylyx (AMLX) Q2 Net Loss Narrows 43%
Amylyx Pharmaceuticals (NASDAQ:AMLX), a biotechnology company focused on treatments for neurodegenerative and endocrine diseases, reported its second quarter 2025 financial results on August 7
Talos Energy (TALO) Q2 2025 Earnings Transcript
Image source: The Motley Fool.
Thursday, August 7, 2025 at 2:00 p.m. ET
President and Chief Executive Officer — Paul Goodfellow
Source Fool.com
Leatt (LEAT) Q2 Revenue Jumps 61%
Leatt (OTC:LEAT), a leading innovator in protective gear and equipment for motorsports and cycling, released its second quarter 2025 financial results on August 7, 2025. The company reported GAAP
Global Partners (GLP) Q2 EPS Falls 50%
Global Partners (NYSE:GLP), a major owner of fuel terminals and gasoline stations in the Northeast U.S, reported its second quarter 2025 results on August 7, 2025. The headline news was that both
Kimbell (KRP) Q2 Revenue Rises 13%
Kimbell Royalty Partners (NYSE:KRP), a mineral and royalty interests company with broad exposure to U.S. oil and gas basins, released its second quarter results on August 7, 2025. The headline news
Cogent (CCOI) Q2 Revenue Falls 5.5%
Cogent Communications (NASDAQ:CCOI), a global provider of high-speed Internet access and private network services, reported its results for the quarter ended June 30, 2025, on August 7, 2025. The
United Homes (UHG) Q2 Revenue Falls 4%
United Homes Group (NASDAQ:UHG), a Southeast-focused homebuilder known for its land-light operations and entry-level offerings, reported earnings for Q2 2025 on August 7, 2025. The most notable
Mbx Biosciences (MBX) Q2 Loss Widens 22%
Mbx Biosciences (NASDAQ:MBX), a clinical-stage biopharmaceutical company developing peptide therapies for endocrine and metabolic diseases, released its second-quarter 2025 results on August 7
Tennant (TNC) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, August 7, 2025 at 2:00 p.m. ET
President and Chief Executive Officer — Dave Huml
Source Fool.com
Phathom (PHAT) Q2 Revenue Jumps 441%
Phathom Pharmaceuticals (NASDAQ:PHAT), a biopharmaceutical company specializing in treatments for gastrointestinal diseases, announced its second quarter 2025 earnings on August 7, 2025. The
Silence (SLN) Q2 Revenue Drops 71%
Silence Therapeutics Plc (NASDAQ:SLN), a biotechnology company focused on developing RNA interference (RNAi) therapeutics, released its second quarter results on August 7, 2025. The company reported
Park-Ohio (PKOH) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, August 7, 2025, at 10 a.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Western Midstream (WES) Earnings Transcript
Image source: The Motley Fool.
Aug. 7, 2025, 2 p.m. ET
Chief Executive Officer — Oscar Brown
Source Fool.com